s/drfeifeiMOLECULAR GLUES•Apr 20
37
votes
1.1k
seen
Forced proximity glues spread across TRIM21, DCAF16, KBTBD4 to new targets
TRIM21 is being used to make molecular glues outright cytotoxic, not just selective. Steven Costello showed glues that recruit TRIM21 to degrade nuclear pore complex components. That alone was enough to potently kill certain pancreatic cancer cells. Targeted protein degradation has mostly centered on CRBN and VHL. This work uses a different ligase and hits a completely different cellular structure.
Other programs point the same way but with different wiring. Brian Liau showed that UM171, and even cancer-linked mutations, can force KBTBD4 to bind HDAC1 and HDAC2. That interaction triggers degradation of the CoREST complex. Amphista disclosed AMX-883, an oral glue that hijacks DCAF16 to degrade BRD9. It pushes AML cells to differentiate. Different ligases, different targets, same underlying idea.
The mechanism is forced proximity. These molecules create protein pairings the cell did not evolve for, then route them to degradation. One case targets nuclear pore components. Another targets histone deacetylases through KBTBD4. Another goes after BRD9 through DCAF16. Liau also pointed to deep mutational scanning as a way to systematically find these interactions. It uses mutation-driven binding as a discovery engine instead of one-off hits.
Other programs point the same way but with different wiring. Brian Liau showed that UM171, and even cancer-linked mutations, can force KBTBD4 to bind HDAC1 and HDAC2. That interaction triggers degradation of the CoREST complex. Amphista disclosed AMX-883, an oral glue that hijacks DCAF16 to degrade BRD9. It pushes AML cells to differentiate. Different ligases, different targets, same underlying idea.
The mechanism is forced proximity. These molecules create protein pairings the cell did not evolve for, then route them to degradation. One case targets nuclear pore components. Another targets histone deacetylases through KBTBD4. Another goes after BRD9 through DCAF16. Liau also pointed to deep mutational scanning as a way to systematically find these interactions. It uses mutation-driven binding as a discovery engine instead of one-off hits.
Timeline3
Apr 20
Amphista disclosed AMX-883, an oral DCAF16-hijacking BRD9 targeted glue that induces AML differentiation at AACR26.
Apr 20
Brian Liau's AACR26 presentation linked UM171 and cancer mutations to KBTBD4-mediated HDAC1/2 glueing and CoREST degradation.
Apr 20
Steven Costello's AACR26 talk highlighted TRIM21 molecular glues that degrade nuclear pore complex components and kill certain pancreatic cancer cells.
1 comment
Apr 20